- Tytuł:
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- Autorzy:
- Źródło:
- Diabetic Medicine; Mar2009, Vol. 26 Issue 3, p268-278, 11p
Czasopismo naukowe